Dr. Thejus Jayakrishnan sat down with CURE on the 2026 ASCO Gastrointestinal Cancers Symposium to debate analysis he offered evaluating how sufferers and physicians weigh remedy choices in later-line metastatic colorectal most cancers.
Jayakrishnan, who’s a gastrointestinal medical oncologist at Dana-Farber Most cancers Institute and Brigham and Girls’s Hospital, was properly as an teacher in drugs at Harvard Medical Faculty, in Boston, explored variations in priorities between sufferers and clinicians, together with survival expectations and quality-of-life issues
Transcript
What had been you making an attempt to raised perceive within the analysis you offered on the ASCO Gastrointestinal Cancers Symposium, significantly relating to how sufferers and physicians make remedy selections in later-line metastatic colorectal most cancers?
I offered a poster… that assessed affected person and doctor decisions when making selections relating to therapies for metastatic colorectal most cancers, particularly within the later-line setting. Later-line means individuals who have had their most cancers progress via earlier remedy methods and are actually requiring a third-line or fourth-line remedy. We checked out how they weigh the alternatives which are accessible.
I’ll inform you briefly in regards to the examine itself. Within the examine, we despatched out surveys to sufferers and in addition to treating suppliers—individuals who deal with people with metastatic colorectal most cancers and administer therapies. We tried to gauge the issues which are essential for them, … but additionally what trade-offs they’re prepared to make. For instance, how a lot survival are you prepared to compromise on in case your high quality of life might be preserved? As a result of these are the form of trade-offs and decisions that physicians and sufferers must make, it was a survey train to gauge priorities and determine what trade-offs persons are prepared to make.
What we discovered was that, clearly, a very powerful attribute for any remedy is survival, or the power to stay longer, for each sufferers and physicians. Nonetheless, we discovered that whereas greater than 50% of the physicians ranked survival because the primary precedence, lower than half of the sufferers truly famous that because the primary factor. This means that high quality of life and hostile occasion issues are essential for sufferers.
We have now remedy choices that embrace oral-only therapies and coverings that embrace tablets plus intravenous infusions. Sufferers and physicians each thought of oral-only tablets as a preferable remedy choice. Then, taking a look at hostile occasions, it was very attention-grabbing as a result of for physicians, a very powerful hostile occasion we had been frightened about was neutropenia, which is principally a drop in blood counts that assist struggle an infection. These are markers that we see on routine blood work which will immediate adjustments in therapies. However for sufferers, the primary consideration was fatigue. That was the principle hostile occasion that sufferers had been frightened about and that they thought would influence their high quality of life when making these decisions.
Transcript has been edited for readability and conciseness.
For extra information on most cancers updates, analysis and training, don’t neglect to
